Global Bipolar Disorder Treatment Market Report and Forecast 2023-2031

Global Bipolar Disorder Treatment Market Report and Forecast 2023-2031

Global Bipolar Disorder Treatment Market Outlook

The global bipolar disorder treatment market size was valued at USD 5.3 billion in 2022 and is projected to grow at a CAGR of 2.5% during the forecast period of 2023-2031 to reach a value of USD 6.7 billion by 2031. The market growth can be attributed to the increasing prevalence of bipolar disorder and the rising awareness about mental health.

Global Bipolar Disorder Treatment Market: Introduction

Bipolar disorder treatment refers to the medical care provided to individuals with bipolar disorder, a mental health condition characterized by episodes of mania and depression. The treatment options include medication, psychotherapy, and other supportive services, such as rehabilitation and counselling. The increasing prevalence of bipolar disorder, along with the rising awareness about mental health, is driving the demand for bipolar disorder treatment. Other factors such as increasing government initiatives, and the growing demand for innovative treatment options are also expected to drive market growth.

Advancements in technology have also played a significant role in the growth of the bipolar disorder treatment market. Digital health tools, such as telemedicine and online therapy platforms, have made bipolar disorder treatment more accessible to people who may have difficulty accessing traditional in-person care. This has expanded the reach of bipolar disorder treatment and helped to meet the growing demand for services. Another factor contributing to the growth of the bipolar disorder treatment market is the changing attitudes towards mental health. In the past, mental health was often stigmatized and not discussed openly. However, in recent years, there has been a growing recognition of the importance of mental health, and a shift towards reducing the stigma associated with mental health conditions. This has led to more people seeking treatment and an increased demand for mental health services.

Bipolar Disorder Epidemiology

According to the World Health Organization, bipolar disorder affects approximately 1% of the global population. Bipolar disorder can affect people of all ages and genders but it typically begins in late adolescence or early adulthood. It is essential to recognize that bipolar disorder and treatment needs can vary significantly among individuals, and that bipolar disorder treatment should be tailored to meet the individual needs of each person. Efforts to improve access to bipolar disorder treatment should take into account the unique needs of different age and gender groups, as well as the underlying factors that contribute to bipolar disorder, such as social determinants of health, genetics, and environmental factors.

Bipolar Disorder Treatment Market Segmentations

The market can be segmented based on mechanism of action, diagnosis methods, treatment methods, treatment channel, and region:

Market Breakup by Mechanism of Action

  • Tricyclic Antidepressants
  • Monoamine Oxidase Inhibitors
  • Benzodiazepines
  • Serotonin-Norepinephrine Reuptake Inhibitors
  • Beta-Blockers
  • Selective Serotonin Reuptake Inhibitors
  • Others
Market Breakup by Diagnosis Method
  • Physical Exam
  • Psychiatric Assessment
  • Mood Charting
Market Breakup by Treatment Method
  • Physical
  • Non-Pharmaceuticals
  • Acupuncture
  • Bright Light Therapy
  • Exercise Therapy
  • Sleep Deprivation
  • Vagus Nerve Stimulation
  • Pharmaceuticals
  • Mood Stabilizers
  • Antidepressants
  • Antipsychotics
  • Adjunctive and Alternative Treatments
  • Psychotherapy
  • Therapies
  • Cognitive Behavioural Therapy
  • Group Therapy
  • Interpersonal and Social Rhythm Therapy
  • Vocational Therapy
Market Breakup by Treatment Channel
  • Public
  • Private
Market Breakup by Region
  • North America
  • United States of America
  • Canada
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others
Bipolar Disorder Treatment Market Scenario

The global bipolar disorder treatment market has experienced significant growth over the past few years, driven by factors such as the increasing prevalence of bipolar disorder, rising awareness about mental health, and the growing demand for innovative treatment options. One key driver of growth in the bipolar disorder treatment market is the increasing prevalence of bipolar disorder.

North America is currently the largest market for bipolar disorder treatment, accounting for a significant share of the global market. The region's large market share is driven by factors such as a high prevalence of bipolar disorder, a well-established healthcare infrastructure, and strong investment in mental health research and development. In addition, the growing adoption of digital mental health technologies, such as teletherapy and online counselling, is further driving the growth of the market in North America. Europe is also a significant market for bipolar disorder treatment, with countries such as the UK, Germany, and France leading the way. The region's market growth is driven by factors such as a large population base, increasing awareness of mental health issues, and government initiatives to address mental health concerns. Additionally, the region has a well-established healthcare system, which supports the delivery of bipolar disorder treatment. Asia Pacific is another region that is experiencing significant growth in the bipolar disorder treatment market. The region's market growth is driven by factors such as a large population base, increasing awareness of mental health concerns, and the growing adoption of digital mental health technologies. In addition, government initiatives to address mental health concerns are helping to drive the growth of the market in the region.

Key Players in the Global Bipolar Disorder Treatment Market

The report provides a detailed analysis of the key players involved in the bipolar disorder treatment market, including their business overview, product portfolio, recent developments, and financial analysis. Some of the major players operating in the market include:
  • GlaxoSmithKline Plc.
  • Novartis International AG
  • Takeda Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Allergan Plc. (AbbVie Inc)
  • AstraZeneca Plc.
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Company
  • Astellas Pharma Inc.
  • Johnson And Johnson Services, Inc.

*Please Note:* The report will be completed in 7 business days after order confirmation


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
2 Research Methodology
3 Executive Summary
4 Bipolar Disorder Overview
4.1 Guidelines and Stages
4.2 Pathophysiology
4.3 Screening and Diagnosis
4.4 Treatment Pathway
5 Patient Profile
5.1 Patient Profile Overview
5.2 Patient Psychology and Emotional Impact Factors
5.3 Risk Assessment and Treatment Success Rate
6 Current Scenario Evaluation and Regulatory Framework
6.1 Emerging Therapies and Clinical Trials Synopsis
6.2 Patent Landscape
6.2.1 Patent Overview
6.2.1.1 Patent Status and Expiry
6.2.1.2 Timelines from Drug Development to Commercial Launch
6.2.1.3 New Drug Application
6.2.1.3.1 Documentation and Approval Process
6.3 Cost of Treatment
6.4 Regulatory Framework
6.4.1 Regulatory Overview
6.4.1.1 US FDA
6.4.1.2 EU EMA
6.4.1.3 INDIA CDSCO
6.4.1.4 JAPAN PMDA
6.4.1.5 Others
7 Challenges and Unmet Needs
7.1 Treatment Pathway Challenges
7.2 Compliance and Drop-Out Analysis
7.3 Awareness and Prevention Gaps
8 Global Bipolar Disorder Treatment Market
8.1 Global Bipolar Disorder Treatment Market Overview
8.2 Global Bipolar Disorder Treatment Market Analysis
8.2.1 Market Overview
8.2.1.1 Global Bipolar Disorder Treatment Market Historical Value (2016-2022)
8.2.1.2 Global Bipolar Disorder Treatment Market Forecast Value (2023-2031)
8.3 Global Bipolar Disorder Treatment Market by Type
8.3.1 Market Overview
8.3.1.1 Bipolar I Disorder
8.3.1.2 Bipolar II Disorder
8.3.1.3 Cyclothymic Disorder
8.4 Global Bipolar Disorder Treatment Market by Mechanism of Action
8.4.1 Market Overview
8.4.1.1 Tricyclic Antidepressants
8.4.1.2 Monoamine Oxidase Inhibitors
8.4.1.3 Benzodiazepines
8.4.1.4 Serotonin-Norepinephrine Reuptake Inhibitors
8.4.1.5 Beta-Blockers
8.4.1.6 Selective Serotonin Reuptake Inhibitors
8.4.1.7 Others
8.5 Global Bipolar Disorder Treatment Market by Diagnosis Method
8.5.1 Market Overview
8.5.1.1 Physical Exam
8.5.1.2 Psychiatric Assessment
8.5.1.3 Mood Charting
8.6 Global Bipolar Disorder Treatment Market by Treatment Method
8.6.1 Market Overview
8.6.1.1 Physical
8.6.1.1.1 Non-Pharmaceuticals
8.6.1.1.1.1 Acupuncture
8.6.1.1.1.2 Bright Light Therapy
8.6.1.1.1.3 Exercise Therapy
8.6.1.1.1.4 Sleep Deprivation
8.6.1.1.1.5 Vagus Nerve Stimulation
8.6.1.1.2 Pharmaceuticals
8.6.1.1.2.1 Mood Stabilizers
8.6.1.1.2.2 Antidepressants
8.6.1.1.2.3 Antipsychotics
8.6.1.1.2.4 Adjunctive and Alternative Treatments
8.6.1.2 Psychotherapy
8.6.1.2.1 Therapies
8.6.1.2.1.1 Cognitive Behavioural Therapy
8.6.1.2.1.2 Group Therapy
8.6.1.2.1.3 Interpersonal and Social Rhythm Therapy
8.6.1.2.1.4 Vocational Therapy
8.7 Global Bipolar Disorder Treatment Market by Treatment Channel
8.7.1 Public
8.7.2 Private
8.8 Global Bipolar Disorder Treatment Market by Region
8.8.1 Market Overview
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 North America Bipolar Disorder Treatment Market
9.1 Market Share by Country
9.2 United States of America
9.2.1 Historical Trend (2016-2022)
9.2.2 Forecast Trend (2023-2031)
9.3 Canada
9.3.1 Historical Trend (2016-2022)
9.3.2 Forecast Trend (2023-2031)
10 Europe Bipolar Disorder Treatment Market
10.1 Market Share by Country
10.2 United Kingdom
10.2.1 Historical Trend (2016-2022)
10.2.2 Forecast Trend (2023-2031)
10.3 Germany
10.3.1 Historical Trend (2016-2022)
10.3.2 Forecast Trend (2023-2031)
10.4 France
10.4.1 Historical Trend (2016-2022)
10.4.2 Forecast Trend (2023-2031)
10.5 Italy
10.5.1 Historical Trend (2016-2022)
10.5.2 Forecast Trend (2023-2031)
10.6 Others
11 Asia Pacific Bipolar Disorder Treatment Market
11.1 Market Share by Country
11.2 China
11.2.1 Historical Trend (2016-2022)
11.2.2 Forecast Trend (2023-2031)
11.3 Japan
11.3.1 Historical Trend (2016-2022)
11.3.2 Forecast Trend (2023-2031)
11.4 India
11.4.1 Historical Trend (2016-2022)
11.4.2 Forecast Trend (2023-2031)
11.5 ASEAN
11.5.1 Historical Trend (2016-2022)
11.5.2 Forecast Trend (2023-2031)
11.6 Australia
11.6.1 Historical Trend (2016-2022)
11.6.2 Forecast Trend (2023-2031)
11.7 Others
12 Latin America Bipolar Disorder Treatment Market
12.1 Market Share by Country
12.2 Brazil
12.2.1 Historical Trend (2016-2022)
12.2.2 Forecast Trend (2023-2031)
12.3 Argentina
12.3.1 Historical Trend (2016-2022)
12.3.2 Forecast Trend (2023-2031)
12.4 Mexico
12.4.1 Historical Trend (2016-2022)
12.4.2 Forecast Trend (2023-2031)
12.5 Others
13 Middle East and Africa Bipolar Disorder Treatment Market
13.1 Market Share by Country
13.2 Saudi Arabia
13.2.1 Historical Trend (2016-2022)
13.2.2 Forecast Trend (2023-2031)
13.3 United Arab Emirates
13.3.1 Historical Trend (2016-2022)
13.3.2 Forecast Trend (2023-2031)
13.4 Nigeria
13.4.1 Historical Trend (2016-2022)
13.4.2 Forecast Trend (2023-2031)
13.5 South Africa
13.5.1 Historical Trend (2016-2022)
13.5.2 Forecast Trend (2023-2031)
13.6 Others
14 Global Bipolar Disorder Treatment Market Dynamics
14.1 Market Drivers and Constraints
14.2 SWOT Analysis
14.3 Porter’s Five Forces Model
14.4 Key Demand Indicators
14.5 Key Price Indicators
14.6 Industry Events, Initiatives and Trends
14.7 Value Chain Analysis
15 Supplier Landscape
15.1 GlaxoSmithKline Plc.
15.1.1 Company Overview
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.1.5 Certifications
15.2 Novartis International AG
15.2.1 Company Overview
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Takeda Pharmaceutical Industries Ltd.
15.3.1 Company Overview
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Pfizer Inc.
15.4.1 Company Overview
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Allergan Plc. (AbbVie Inc)
15.5.1 Company Overview
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 AstraZeneca Plc.
15.6.1 Company Overview
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Bristol-Myers Squibb Co.
15.7.1 Company Overview
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Eli Lilly and Company
15.8.1 Company Overview
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Astellas Pharma Inc.
15.9.1 Company Overview
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Johnson And Johnson Services, Inc.
15.10.1 Company Overview
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
16 Global Bipolar Disorder Treatment Market- Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings